We are live on ! Find out more
IVVD icon

Invivyd
IVVD

59 hedge funds and large institutions have $220M invested in Invivyd in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

248% more call options, than puts

Call options by funds: $623K | Put options by funds: $179K

142% more capital invested

Capital invested by funds: $90.9M → $220M (+$129M)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1.94% more ownership

Funds ownership: 48.72% → 50.67% (+1.9%)

2% more funds holding

Funds holding: 58 → 59 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 17

Holders
59
Holders Change
+1
Holders Change %
+1.72%
% of All Funds
0.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
17
Reduced
17
Closed
10
Calls
$623K
Puts
$179K
Net Calls
+$444K
Net Calls Change
+$447K

Top Buyers

1
MC
Maverick Capital
Texas
+$7.7M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$862K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$664K
4
Jane Street
Jane Street
New York
+$307K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$197K

Top Sellers

1
O
OrbiMed
New York
-$2.16M
2
Millennium Management
Millennium Management
New York
-$1.21M
3
6CM
683 Capital Management
New York
-$757K
4
TCM
Tang Capital Management
California
-$623K
5
Citigroup
Citigroup
New York
-$453K
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
1
Maverick Capital
Texas
$36.8M +$7.7M +4,073,659 +77%
MCM
2
M28 Capital Management
Connecticut
$36.4M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$33.1M +$664K +351,030 +4%
AI
4
Alphabet Inc
California
$22.4M – – –
O
5
OrbiMed
New York
$16.3M -$2.16M -1,142,835 -22%
SPC
6
Slate Path Capital
New York
$14.7M – – –
6CM
7
683 Capital Management
New York
$14.2M -$757K -400,000 -10%
Vanguard Group
8
Vanguard Group
Pennsylvania
$9.9M +$46.7K +24,692 +1%
BCLSI
9
Bain Capital Life Sciences Investors
Massachusetts
$7.63M – – –
RG
10
Redmile Group
California
$5.68M – – –
BlackRock
11
BlackRock
New York
$3.55M -$438K -231,416 -20%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$2.29M +$70.8K +37,430 +7%
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$2.03M +$862K +455,486 +761%
BCM
14
Bridgeway Capital Management
Texas
$2.01M +$125K +66,000 +15%
Millennium Management
15
Millennium Management
New York
$1.8M -$1.21M -638,552 -58%
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$1.41M -$114K -60,217 -14%
Charles Schwab
17
Charles Schwab
California
$1.2M +$68.9K +36,435 +14%
Citigroup
18
Citigroup
New York
$1.06M -$453K -239,440 -47%
AI
19
Acuitas Investments
Washington
$822K +$115 +61 +0%
Jane Street
20
Jane Street
New York
$763K +$307K +162,351 +520%
State Street
21
State Street
Massachusetts
$691K -$1.7K -900 -0.5%
RC
22
RBF Capital
California
$591K -$102K -53,683 -26%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$480K +$197K +104,007 +584%
Northern Trust
24
Northern Trust
Illinois
$414K -$2.29K -1,212 -1%
Squarepoint
25
Squarepoint
New York
$403K -$197K -104,027 -50%
1
2 3

IVVD Hedge Fund Activity: Q4 2023 in Review

59 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Invivyd (IVVD) for Q4 2023, worth a combined $220M — up 142% from $90.9M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new IVVD positions and 10 closed out — a net gain of 1 holder — while 17 added to existing stakes and 17 trimmed.

The largest buyer was Maverick Capital, adding an estimated $7.7M. The largest seller was OrbiMed, cutting an estimated $2.16M.

  • 59 institutional investors held Invivyd (IVVD) as of Q4 2023, up from 58 in Q3 2023.
  • Funds reported $220M of Invivyd stock for Q4 2023, up 142% quarter-over-quarter.
  • 11 funds opened new Invivyd positions in Q4 2023 and 10 closed out, a net change of +1 holder.
  • The largest Invivyd buyer in Q4 2023 was Maverick Capital, an estimated $7.7M added.
  • The largest Invivyd seller in Q4 2023 was OrbiMed, an estimated $2.16M sold.

Based on aggregated 13F filings for Q4 2023.